KTYCF (Kits Eyecare) EBIT: $5.2 Mil (TTM As of Mar. 2026)


KTYCF Kits Eyecare Ltd KTYCF
74 GF Score
Price $8.86
GF Value $10.23
Valuation Modestly Undervalued
! 1 Warning Sign
View Full Analysis

What is Kits Eyecare EBIT?

Kits Eyecare KTYCF -1.37% 74 EBIT is $5.2 Mil as of Mar. 2026. GuruFocus rates KTYCF with a GF Score™ of 74/100 and a GF Value™ of $10.23 (Modestly Undervalued). The stock has 1 warning sign investors should review.

Kits Eyecare's earnings before interest and taxes (EBIT) for the three months ended in Mar. 2026 was $2.8 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2026 was $5.2 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Kits Eyecare's annualized ROC % for the quarter that ended in Mar. 2026 was 12.99%. Kits Eyecare's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 154.18%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Kits Eyecare's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 1.80%.


Kits Eyecare  (OTCPK:KTYCF) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Kits Eyecare's annualized ROC % for the quarter that ended in Mar. 2026 is calculated as:

ROC % (Q: Mar. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2025 ) + Invested Capital (Q: Mar. 2026 ))/ count )
=9.316 * ( 1 - 33.09% )/( (51.266 + 44.729)/ 2 )
=6.2333356/47.9975
=12.99 %

where

Note: The Operating Income data used here is four times the quarterly (Mar. 2026) data.

2. Joel Greenblatt's definition of Return on Capital:

Kits Eyecare's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 is calculated as:

ROC (Joel Greenblatt) %(Q: Mar. 2026 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2025  Q: Mar. 2026
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=11.376/( ( (6.611 + max(-5.367, 0)) + (6.418 + max(1.728, 0)) )/ 2 )
=11.376/( ( 6.611 + 8.146 )/ 2 )
=11.376/7.3785
=154.18 %

where Working Capital is:

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(1.607 + 17.158 + 0.71099999999999) - (19.519 + 5.324 + 7.105427357601E-15)
=-5.367

Working Capital(Q: Mar. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(3.874 + 19.934 + 0.85899999999999) - (17.626 + 5.313 + 0)
=1.728

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Kits Eyecare's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Mar. 2026 )
=5.186/287.774
=1.80 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Kits Eyecare EBIT Related Terms


Kits Eyecare EBIT Historical Data

* Premium members only.

The historical data trend for Kits Eyecare's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kits Eyecare EBIT Chart

Kits Eyecare Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EBIT
Get a 7-Day Free Trial -13.56 -3.13 -0.99 3.97 4.15

Kits Eyecare Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.73 -0.26 1.95 0.65 2.84

KTYCF vs CASY, WSM, ULTA: EBIT Comparison

For the Specialty Retail subindustry, Kits Eyecare's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Kits Eyecare EV-to-EBIT vs Retail - Cyclical Industry

For the Retail - Cyclical industry and Consumer Cyclical sector, Kits Eyecare's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Kits Eyecare's EV-to-EBIT falls into.


KTYCF
74GF Score
Kits Eyecare Ltd KTYCF
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Kits Eyecare EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $5.2 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of $5.2 Mil mean?
Kits Eyecare (KTYCF) has a EBIT of $5.2 Mil as of Mar. 2026. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Kits Eyecare.
Is Kits Eyecare's EBIT too high?
Kits Eyecare's current EBIT is $5.2 Mil. Overall, Kits Eyecare has a GF Score™ of 74/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Kits Eyecare's EBIT compare to CASY and WSM?
Kits Eyecare's EBIT of $5.2 Mil can be compared against companies in the Retail - Cyclical industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Retail - Cyclical company?
A good EBIT depends on the Retail - Cyclical industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Kits Eyecare. Kits Eyecare's current EBIT is $5.2 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kits Eyecare stock overvalued right now?
Based on GuruFocus' analysis, Kits Eyecare (KTYCF) is currently considered Modestly Undervalued. The stock's GF Value™ is $10.23, compared to a current price of $8.86 — trading 13.4% below its estimated fair value. The current EBIT is $5.2 Mil. Kits Eyecare's overall GF Score™ is 74/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Kits Eyecare (KTYCF), the current EBIT is $5.2 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Kits Eyecare (KTYCF) Overvalued in 2026?

Based on GuruFocus' analysis, Kits Eyecare stock appears to be undervalued. The current stock price of $8.86 is trading 13.4% below its estimated GF Value™ of $10.23. GuruFocus considers Kits Eyecare to be Modestly Undervalued.

Key valuation signals for KTYCF:

  • EBIT: $5.2 Mil
  • GF Value™: $10.23 vs. price of $8.86 (13.4% below fair value)
  • GF Score™: 74/100 with 1 warning sign

No single metric tells the full story. See the KTYCF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Kits Eyecare Business Description

Other Exchanges 0P3:GermanyKITS:Canada
Address 510 Seymour Street, Suite 1020, Vancouver, BC, CAN, V6B 3J5
Kits Eyecare Ltd is a vertically integrated, digitally native eyecare platform that offers its customers access to a vast selection of the highest quality contact lenses and eyeglasses, including its exclusive KITS-designed products, and a suite of online vision tools. It operates a network of optical e-commerce websites, including KITS.com, KITS.ca, OptiContacts.com, and ContactsExpress.ca. The company's contact lens partners include Alcon, Bausch & Lomb, CooperVision, and Johnson & Johnson, and its glasses partners include Gucci, Oakley, Prive Revaux, Ray-Ban and Tom Ford. Its geographic locations are the United States; and Canada and Other which generates the majority of its revenue from the United States.
74GF Score

Get the complete analysis for KTYCF

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$8.86
Price
$10.23
GF Value